RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable

RST introduces Demron-C line of Covid-19 anti-viral reusable personal protective equipment (PPE) for Coronavirus first responders & healthcare workers

Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts - ScienceDirect

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Why the Odds Are Stacked Against a Promising New Covid Drug - The New York Times

Regeneron's antibody COVID-19 treatment is popular in the U.S. — why not in Canada? - National

Seeking COVID-19 therapeutic candidates with a computational approach

Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts - ScienceDirect

RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable PPE - PreScouter

What We Read: Pandemic Edition

New made-in-Canada research tool in the fight against COVID-19 - National Research Council Canada